![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 223/16 | (2006.01) |
A61K 31/55 | (2006.01) | ||
A61P 3/04 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61P 25/24 | (2006.01) |
(11) | Number of the document | 1838677 |
(13) | Kind of document | T |
(96) | European patent application number | 05855526.9 |
Date of filing the European patent application | 2005-12-20 | |
(97) | Date of publication of the European application | 2007-10-03 |
(45) | Date of publication and mention of the grant of the patent | 2009-09-09 |
(46) | Date of publication of the claims translation | 2009-12-28 |
(86) | Number | PCT/US2005/046983 |
Date | 2005-12-20 |
(87) | Number | WO 2006/069363 |
Date | 2006-06-29 |
(30) | Number | Date | Country code |
638221 P | 2004-12-21 | US |
(72) |
AGARWAL, Rajesh Kumar, US
BETTS, III, William L., US
HENSHILWOOD, James A., US
KIANG, Yuan-Hon, US
POST, Noah, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6166 Nancy Ridge Drive, San Diego, CA 92121-3223,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | (R)-8-Chlor-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepino hidrochlorido hemihidrato kristalinės formos |
CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL- 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE |
Payment date | Validity (years) | Amount | |
2024-12-03 | 20 | 347.00 EUR |